Evidence map›Paper›PMID 25408889›Full record

ArticleCell regeneration (London, England)2014

Production of transgenic pigs over-expressing the antiviral gene Mx1.

Quanmei Yan, Huaqiang Yang, Dongshan Yang, Bentian Zhao, Zhen Ouyang, Zhaoming Liu, Nana Fan, Hongsheng Ouyang, Weiwang Gu, Liangxue Lai

Open access · diamondAbstract read
In one paragraph

Article in Cell regeneration (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Pigs lackingFrontiers in genome editing · 2023
    Article
  3. Article
  4. Review
  5. Review
  6. Extensive germline genome engineering in pigs.Nature biomedical engineering · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Quanmei YanGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Huaqiang YangGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Dongshan YangGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Bentian ZhaoGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Zhen OuyangGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Zhaoming LiuGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Nana FanGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Hongsheng OuyangCollege of Animal Sciences, Jilin University, Changchun, China.
Weiwang GuInstitute of Comparative Medicine and Center of Laboratory Animals, Southern Medical University, Guangzhou, China.
Liangxue LaiGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China ; College of Animal Sciences, Jilin University, Changchun, China.
Chinese Academy of Sciences · CNJilin University · CNGuangzhou Institutes of Biomedicine and Health · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The myxovirus resistance gene (Mx1) has a broad spectrum of antiviral activities. It is therefore an interesting candidate gene to improve disease resistance in farm animals. In this study, we report the use of somatic cell nuclear transfer (SCNT) to produce transgenic pigs over-expressing the Mx1 gene. These transgenic pigs express approximately 15-25 times more Mx1 mRNA than non-transgenic pigs, and the protein level of Mx1 was also markedly enhanced. We challenged fibroblast cells isolated from the ear skin of transgenic and control pigs with influenza A virus and classical swine fever virus (CFSV). Indirect immunofluorescence assay (IFA) revealed a profound decrease of influenza A proliferation in Mx1 transgenic cells. Growth kinetics showed an approximately 10-fold reduction of viral copies in the transgenic cells compared to non-transgenic controls. Additionally, we found that the Mx1 transgenic cells were more resistant to CSFV infection in comparison to non-transgenic cells. These results demonstrate that the Mx1 transgene can protect against viral infection in cells of transgenic pigs and indicate that the Mx1 transgene can be harnessed to develop disease-resistant pigs.

Indexed as

Antiviral breedingInnate resistanceSomatic cell nuclear transfer

Identifiers

PMID25408889
PMCPMC4230515
OpenAlexW2153303577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.